Andrew J. Last - 01 Sep 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: EVP, Chief Operating Officer
Issuer ticker: BIO
Reported as of: 01 Sep 2024
Net transaction value: -$625,391
SEC form: 4
Accepted by SEC: 04 Sep 2024, 20:19:54 UTC
Prior SEC filing: 03 Jul 2024
Next SEC filing: 10 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew J. Last

Key filing fact

Andrew J. Last filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 04 Sep 2024.

Key facts

This page summarizes Andrew J. Last's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
12 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 04 Sep 2024, 20:19.

Change

Previous filing in this sequence was filed on 03 Jul 2024.
Current net transaction value: -$625,391.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO BIOB transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +1,252
Change %: +22%
Price: $0.000000
Shares after: 7,010
Date: 01 Sep 2024
Ownership: Direct
Footnotes: F1, F2

BIO BIOB transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $214,198
Shares: -635
Change %: -9.1%
Price: $337.32
Shares after: 6,375
Date: 01 Sep 2024
Ownership: Direct

BIO BIOB transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +867
Change %: +14%
Price: $0.000000
Shares after: 7,242
Date: 01 Sep 2024
Ownership: Direct
Footnotes: F1

BIO BIOB transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $148,421
Shares: -440
Change %: -6.1%
Price: $337.32
Shares after: 6,802
Date: 01 Sep 2024
Ownership: Direct

BIO BIOB transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +633
Change %: +9.3%
Price: $0.000000
Shares after: 7,435
Date: 01 Sep 2024
Ownership: Direct
Footnotes: F1

BIO BIOB transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $108,280
Shares: -321
Change %: -4.3%
Price: $337.32
Shares after: 7,114
Date: 01 Sep 2024
Ownership: Direct

BIO BIOB transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +903
Change %: +13%
Price: $0.000000
Shares after: 8,017
Date: 02 Sep 2024
Ownership: Direct
Footnotes: F1

BIO BIOB transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $154,493
Shares: -458
Change %: -5.7%
Price: $337.32
Shares after: 7,559
Date: 02 Sep 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO BIOB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,252
Change %: -25%
Price: $0.000000
Shares after: 3,756
Date: 01 Sep 2024
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 1,252
Exercise price: $0.000000
Footnotes: F3, F4

BIO BIOB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -867
Change %: -33%
Price: $0.000000
Shares after: 1,735
Date: 01 Sep 2024
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 867
Exercise price: $0.000000
Footnotes: F3, F5

BIO BIOB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -633
Change %: -50%
Price: $0.000000
Shares after: 633
Date: 01 Sep 2024
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 633
Exercise price: $0.000000
Footnotes: F3, F6

BIO BIOB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -903
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 02 Sep 2024
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 903
Exercise price: $0.000000
Footnotes: F3, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Includes 38.5620 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F4

On September 1, 2023, the reporting person was granted 5,008 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F5

On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F6

On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F7

On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.